Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-1-20
|
pubmed:abstractText |
A sandwich transfer enzyme immunoassay for salmon calcitonin (SCT) and its usability for the pharmacokinetic study are described. The assay procedure consisted of the reaction of SCT with 2,4-dinitrophenyl biotinyl anti-SCT IgG and anti-SCT Fab'-beta-galactosidase conjugate, trapping onto (anti-2,4-dinitrophenyl bovine serum albumin) IgG-coated polystyrene balls, eluting with epsilon N-2,4-dinitrophenyl-L-lysine and transferring to streptavidin-coated polystyrene balls and fluorometric detection of beta-D-galactosidase activity. The practical detection limit of SCT was 0.05 pg (15 amol)/50 microliters of sample and 1 pg/ml as the concentration. The application of this method has enabled us to directly estimate the bioavailability of SCT dosed intranasally at the therapeutic level (160 IU, 31 micrograms) for its anti-osteoporotic effect as compared to an intramuscular dose (10 IU, 1.9 micrograms). The pharmacokinetic parameters of the intranasal SCT (n = 6) thus estimated were as follows: the area under the blood concentration-time curve (AUC) 9400 +/- 5400 (SD) pg.h/ml, and the mean residence time (MRT) = 42 +/- 14 (SD) min, when the AUC for the intramuscular SCT (n = 3) = 5600 +/- 2000 (SD) pg.h/ml and the MRT = 39 +/- 19 (SD) min.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,4-Dinitrophenol,
http://linkedlifedata.com/resource/pubmed/chemical/Calcitonin,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fab Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Albumin, Bovine,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Galactosidase,
http://linkedlifedata.com/resource/pubmed/chemical/salmon calcitonin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0887-8013
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
380-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9406061-2,4-Dinitrophenol,
pubmed-meshheading:9406061-Administration, Intranasal,
pubmed-meshheading:9406061-Adult,
pubmed-meshheading:9406061-Biological Availability,
pubmed-meshheading:9406061-Biotinylation,
pubmed-meshheading:9406061-Calcitonin,
pubmed-meshheading:9406061-Drug Stability,
pubmed-meshheading:9406061-Humans,
pubmed-meshheading:9406061-Immunoenzyme Techniques,
pubmed-meshheading:9406061-Immunoglobulin Fab Fragments,
pubmed-meshheading:9406061-Immunoglobulin G,
pubmed-meshheading:9406061-Kinetics,
pubmed-meshheading:9406061-Male,
pubmed-meshheading:9406061-Microspheres,
pubmed-meshheading:9406061-Sensitivity and Specificity,
pubmed-meshheading:9406061-Serum Albumin, Bovine,
pubmed-meshheading:9406061-beta-Galactosidase
|
pubmed:year |
1997
|
pubmed:articleTitle |
A sandwich transfer enzyme immunoassay for salmon calcitonin: determination of the bioavailability of intranasal salmon calcitonin in human.
|
pubmed:affiliation |
Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|